CoChat

An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study

Open access
Nakamura, Kota, Zhu, Zhongxu, Roy, Souvick, Jun, Eunsung, Han, Haiyong, Munoz, Ruben M., Nishiwada, Satoshi, Sharma, Geeta, Cridebring, Derek, Zenhausern, Frederic, Kim, Seungchan, Roe, Denise J., Darabi, Sourat, Han, In-Woong, Evans, Douglas B., Yamada, Suguru, Demeure, Michael J., Becerra, Carlos, Celinski, Scott A., Borazanci, Erkut, Tsai, Susan, Kodera, Yasuhiro, Park, Joon Oh, Bolton, John S., Wang, Xin, Kim, Song Cheol, Von Hoff, Daniel, Goel, Ajay · 2022 · Gastroenterology
Cited by 166

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background & Aims: Pancreatic ductal adenocarcinoma (PDAC) incidence is rising worldwide, and majority of patients present with an unresectable disease at initial diagnosis. Measurement of carbohydrate antigen 19-9 (CA19-9) levels lack adequate sensitivity and specificity for early detection; hence, there is an unmet need to develop alternate molecular diagnostic biomarkers for PDAC. Emerging evidence suggests that tumor-derived exosomal cargo, particularly miRNAs, offer an attractive platform for the development of cancer-specific biomarkers. Herein, genomewide profiling in blood specimens was performed to develop an exosome-based transcriptomic signature for noninvasive and early detection of PDAC. Methods: Small RNA-sequencing was undertaken in a cohort of 44 patients with an early-stage PDAC and 57 non-disease controls. Using machine-learning algorithms, a panel of cell-free (cf) and exosomal (exo) miRNAs was prioritized that discriminated PDAC patients from control subjects. Subsequently, the performance of the biomarkers was trained and validated in independent cohorts (n=191) using quantitative real time PCR (qRT-PCR) assays. Results: The sequencing analysis initially identified a panel of 30 overexpressed miRNAs in PDAC. Subsequently using qRT-PCR assays, the panel was reduced to 13 markers (5 cf- and 8 exo-miRNAs), which successfully identified patients with all stages of PDAC (AUC=0.98 training cohort; AUC=0.93 validation cohort); but more importantly, was equally robust for the identification of early-stage PDAC (stages 1&II; AUC=0.93). Furthermore, this transcriptomic signature successfully identified CA19-9 negative cases (<37 U/ml; AUC=0.96), when analyzed in combination with CA19-9 levels, significantly improved the overall diagnostic accuracy (AUC=0.99 vs. AUC=0.86 for CA19-9 alone). Conclusions: In this study, an exosome-based liquid-biopsy signature for the noninvasive and robust detection of patients with PDAC was developed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2022.06.090

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Metadata

Authors
Nakamura, K., Zhu, Z., Roy, S., Jun, E., Han, H., Munoz, R. M., Nishiwada, S., Sharma, G., Cridebring, D., Zenhausern, F., Kim, S., Roe, D. J., Darabi, S., Han, I.-W., Evans, D. B., Yamada, S., Demeure, M. J., Becerra, C., Celinski, S. A., Borazanci, E., Tsai, S., Kodera, Y., Park, J. O., Bolton, J. S., Wang, X., Kim, S. C., Von Hoff, D., & Goel, A.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2022-11
Volume
163
Issue
5
Pages
1252-1266.e2
ISSN
0016-5085 (ISSN-L)
OpenAlex
W4285600552
Cited by
166
References
17
FWCI
9.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. https://app.cochat.ai/papers/10.1053/j.gastro.2022.06.090
The paper
Nakamura, K., Zhu, Z., Roy, S., Jun, E., Han, H., Munoz, R. M., Nishiwada, S., Sharma, G., Cridebring, D., Zenhausern, F., Kim, S., Roe, D. J., Darabi, S., Han, I.-W., Evans, D. B., Yamada, S., Demeure, M. J., Becerra, C., Celinski, S. A., . . . Goel, A. (2022). An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Gastroenterology. https://doi.org/10.1053/j.gastro.2022.06.090

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.